Articoli 2016-2012

The contribution of patients’ lung function to the inspiratory airflow rate achievable through a DPIs’ simulator reproducing different intrinsic resistance rates. (Dal Negro R W, Turco P, Povero M. - Multidis Res Med 2021 Apr.)

Valutazione clinica ed economica dell’introduzione sul mercato italiano della combinazione trametinib + dabrafenib nel trattamento del melanoma in stadio avanzato. (Pradelli L, Ascierto P. - Farmeconomia. Health economics and therapeutic pathways 2016; 17(Suppl 3): 1-32)

Cultural and linguistic validation of the NHQ-2 Questionnaire: a specific instrument for assessing patient’s usability of inhalation devices. (Dal Negro W, Povero M - Multidiscip Respir Med. 2016 Aug 23;11:32)

Dry-powder inhalers in patients with persistent airflow limitation: usability and preference. (Dal Negro W, Povero M. - Multidiscip Respir Med. 2016 Sep 5;11:31)

Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients. (Dal Negro W, Povero M. - Multidiscip Respir Med. 2016 Feb 10;11:7)

Simulating the development and progression of Chronic Kidney Disease and osteoporosis in people living with HIV. (Adami S, Maggi P, Montinaro V, Povero M, Pradelli L, Bellagamba R, Bonfanti P, Di Biagio A, Rusconi S, Di Campli FM, Forastieri G, Mancini M. - Farmeconomia. Health economics and therapeutic pathways 2016;17(S1):3-23)

Structured triglycerides versus physical mixtures of medium- and long-chain triglycerides for parenteral nutrition in surgical or critically ill adult patients: Systematic review and meta-analysis. (Wu GH, Zaniolo O, Schuster H, Schlotzer E, Pradelli L. - Clinical Nutrition, epub available online 21 January 2016)

Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysis (Povero M, Pradelli L. - Farmeconomia. Health economics and therapeutic pathways 2015;16(S1):3-16.)

Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US. (Povero M, Pradelli L. - Farmeconomia. Health economics and therapeutic pathways 2015;16(3):77-86.)

Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition. (Wu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL. - MClinicoecon Outcomes Res. 2015 Jun 26;7:369-75.)

Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. (Pradelli L, Povero M, Muscaritoli M, Eandi M. - Eur J Clin Nutr 2015 May;69(5):546-51)

Plasma for fractionation in a public setting: cost analysis from the perspective of the third-party payer. (Eandi M, Gandini G, Povero M, Zaniolo O, Pradelli L, Aprili G. - Blood Transfus 2015 Jan;13(1):37-45)

Comparative pharmaco-economic assessment of apixaban versus standard of care for the prevention of stroke in Italian atrial fibrillation patients. (Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. - Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 15-25)

Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients. (Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. - Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 5-14)

Cost effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients. (Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. - Farmeconomia. Health economics and therapeutic pathways 2014; 15(4): 101-112)

Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study. (Mancini N, Sambri V, Corti C, Ghidoli N, Tolomelli G, Paolucci M, Clerici D, Carletti S, Greco R, Tassara M, Pizzorno B, Zaniolo O, Povero M, Pradelli L, Burioni R, Stanzani M, Landini MP, Ciceri F, Clementi M. - Expert Rev Mol Diagn 2014; 14(5): 623-32)

Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. (Pradelli L, Eandi M, Povero M, Mayer K, Muscaritoli M, Heller AR, Fries-Schaffner E. - Clin Nutr 2014; 33(5): 785-92)

Real-life cost and cost-effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48-month survey. (Povero M, Pradelli L, Turco P, Dal Negro RW. - Farmeconomia. Health economics and therapeutic pathways 2014; 15(2): 39-44)

Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective. (Paggiaro P, Patel S, Nicolini G, Pradelli L, Zaniolo O, Papi A. - Respir Med 2013; 107(10): 1531-7)

A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations. (Bellone M, Sbarra P. - Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 153-160)

ISPOR 2013: what’s new and what’s old? (Zaniolo O, Povero M. - Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 151-152)

First-line HIV treatment: evaluation of backbone choice and its budget impact. (Zaniolo O, Povero M, Bonfanti P, Borderi M, Medaglia M. - Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 75-87)

Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. (Eandi M, Pradelli L, Povero M. - Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 51-74)

n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. (Pradelli L, Mayer K, Muscaritoli M, Heller AR. - Crit Care 2012; 16(5): R184)

A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in Italy. (Dal Negro RW, Tognella S, Pradelli L. - J Asthma 2012; 49(8): 843-8)

Perceval Sutureless valves in isolated and concomitant AVR procedures: an economic model shows overall decrease of costs for isolated or combined operations. (Pradelli L, Zaniolo O. - Farmeconomia. Health economics and therapeutic pathways 2012; 13(4): 159-174)

Effectiveness and Cost-Effectiveness of Supplemental Glutamine Dipeptide in Total Parenteral Nutrition Therapy for Critically Ill Patients: A Discrete Event Simulation Model Based on Italian data. (Pradelli L, Iannazzo S, Zaniolo O, Muscaritoli M, Eandi M. - International Journal of Technology Assessment in Health Care 2012; 28(1): 22–28)

A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five European countries. (Iannazzo S, Carsi M, Chiroli S. - Appl Health Econ Health Policy 2012; 10(2): 127-38)

Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy. (Zaniolo O, Iannazzo S, Pradelli L, Miravitlles M. - Eur J Health Econ 2012; 13(1): 71-80)